HOME >> BIOLOGY >> NEWS
Seminal RNAi innovation is cleared for patenting in Australia

Washington, DC -- The Carnegie Institution of Washington and the University of Massachusetts Medical School announced today that opposition in Australia to the grant of the institutions' patent application related to the discovery of RNAi has been withdrawn. The opposition was originally filed by Benitec, an Australian biotechnogy company, in November 2004. Announcement of the withdrawal will be published in Australia's Official Journal of Patents on August 3, 2006.

Gary Kowalczyk, Carnegie's director of administration and finance, remarked: "The work by Drs. Mello, Fire, and others is widely recognized as the seminal intellectual property in the field of RNAi, and we are pleased that the process of granting a patent in Australia will now move forward. We look forward to companies in Australia licensing this intellectual property, and anticipate similar developments in other countries in the future."

The patent, known popularly as the Fire and Mello patent, was first granted in the United States by the United States Patent and Trademark Office in 2003. Additional patent rights in the United States and elsewhere are pending. To date, the Carnegie Institution, acting upon behalf of itself and the University of Massachusetts Medical School under an interinstitutional agreement, has granted approximately 50 non-exclusive licenses to companies using this invention.

The patent covers a process by which ribonucleic acid (RNA), the cellular material responsible for the transmission of genetic information, can silence a targeted gene within a living cell. The process, called RNA interference (RNAi), can shut down disease-causing genes or direct researchers to pathways for effective drug development.


'"/>

Contact: Gary Kowalczyk
gkowalczyk@ciw.edu
202-939-1118
Carnegie Institution
20-Jul-2006


Page: 1

Related biology news :

1. Canadian paper innovation holds promise for improved global health safety
2. Science academies issue statements on energy efficiency, innovation
3. Recognized innovation
4. Boston University, Fraunhofer Gesellschaft form alliance to accelerate biomedical innovation
5. Yales Strobel named million-dollar professor for science teaching innovation
6. PET shows promise, innovation in detecting, monitoring cancers specific to women
7. UN General Assembly urged to strengthen worldwide capacities in science, technology, and innovation
8. California Institute researchers unveil computer graphics innovations at SIGGRAPH
9. Hamill Foundation funds innovation program at Rice
10. Survey seeks top scientists for study of research creativity and innovation
11. Future Vision 2005 to feature innovation in endoscopy

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/31/2020)... ... July 30, 2020 , ... BioFactura, ... contract awarded by the Joint Science & Technology Office—Chemical and Biological Defense (JSTO-CBD) ... develop, optimize, and scale-up a highly efficient mammalian cell culture-based bioprocess suitable to ...
(Date:7/10/2020)... FALLS CHURCH, Va. (PRWEB) , ... July 08, ... ... , The Latest on Cell and Gene Therapy Regulation, An FDAnews Webinar, Wednesday, ... product may need a comparability study, but what is the most effective way ...
(Date:7/1/2020)... N.J. (PRWEB) , ... July 01, 2020 , ... ... announced that it had completed the purchase of Teva-Takeda Pharmaceuticals’ packaging facility in ... the company’s existing Japanese clinical supply facility located in Kakegawa, the new 60,000-square-foot ...
Breaking Biology News(10 mins):
(Date:7/18/2020)... ... July 16, 2020 , ... “We are thrilled to ... Bioactives. “It’s the only technology of its kind on the market and we were ... with the protective capacity of traditional cultured ingredients, creating a natural way to extend ...
(Date:7/18/2020)... TORONTO (PRWEB) , ... July 17, 2020 , ... ... and global consulting firm for the life sciences and food industries, is pleased ... new Director of Clinical Research – Business Development. , Charles is an accomplished ...
(Date:7/10/2020)... , ... July 09, 2020 ... ... company, announced today that Massachusetts Institute of Technology (MIT) has expanded the ... license allows PathSensors to move into the point-of-care diagnostic market, focusing initially ...
(Date:7/10/2020)... ... July 09, 2020 , ... Sentien Biotechnologies, Inc., a clinical-stage ... Allen R. Nissenson, M.D., F.A.C.P., as its Chief Medical Officer. Dr. Nissenson ... product, SBI-101. Dr. Nissenson serves as an Emeritus Professor of Medicine at ...
Breaking Biology Technology:
Cached News: